Earnings Feed
Start Free
Home/Filings/4/0001628280-26-001976
4//SEC Filing

FRIEDMAN PAUL A 4

Accession 0001628280-26-001976

CIK 0001157601other
View on SEC.govCompany Profile

Filed

Jan 12, 7:00 PM ET

Accepted

Jan 13, 4:43 PM ET

Size

54.0 KB

Accession

0001628280-26-001976

Insider Transaction Report

Form 4
Period: 2026-01-09
MADRIGAL PHARMACEUTICALS, INC.MDGL
FRIEDMAN PAUL A
Director
Transactions
  • Exercise/Conversion

    Common Stock

    2026-01-09$15.80/sh+24,520$387,416→ 211,684 total
  • Sale

    Common Stock

    [F1][F2]
    2026-01-09$511.98/sh−1,480$757,727→ 210,204 total
  • Sale

    Common Stock

    [F1][F3]
    2026-01-09$513.11/sh−1,094$561,340→ 209,110 total
  • Sale

    Common Stock

    [F1][F4]
    2026-01-09$514.68/sh−1,345$692,246→ 207,765 total
  • Sale

    Common Stock

    [F1][F5]
    2026-01-09$515.81/sh−1,996$1,029,561→ 205,769 total
  • Sale

    Common Stock

    [F1][F6]
    2026-01-09$516.84/sh−766$395,896→ 205,003 total
  • Sale

    Common Stock

    [F1][F7]
    2026-01-09$517.86/sh−2,450$1,268,755→ 202,553 total
  • Sale

    Common Stock

    [F1][F8]
    2026-01-09$518.68/sh−1,363$706,966→ 201,190 total
  • Sale

    Common Stock

    [F1][F9]
    2026-01-09$519.88/sh−846$439,822→ 200,344 total
  • Sale

    Common Stock

    [F1][F10]
    2026-01-09$521.03/sh−681$354,823→ 199,663 total
  • Sale

    Common Stock

    [F1][F11]
    2026-01-09$521.98/sh−840$438,461→ 198,823 total
  • Sale

    Common Stock

    [F1][F12]
    2026-01-09$523.00/sh−970$507,307→ 197,853 total
  • Sale

    Common Stock

    [F1][F13]
    2026-01-09$524.10/sh−1,199$628,394→ 196,654 total
  • Sale

    Common Stock

    [F1][F14]
    2026-01-09$525.05/sh−2,432$1,276,916→ 194,222 total
  • Sale

    Common Stock

    [F1][F15]
    2026-01-09$526.00/sh−1,066$560,717→ 193,156 total
  • Sale

    Common Stock

    [F1][F16]
    2026-01-09$526.97/sh−1,560$822,071→ 191,596 total
  • Sale

    Common Stock

    [F1][F17]
    2026-01-09$528.18/sh−575$303,702→ 191,021 total
  • Sale

    Common Stock

    [F1][F18]
    2026-01-09$529.17/sh−691$365,653→ 190,330 total
  • Sale

    Common Stock

    [F1][F19]
    2026-01-09$529.76/sh−166$87,941→ 190,164 total
  • Sale

    Common Stock

    [F1][F20]
    2026-01-09$530.69/sh−280$148,592→ 189,884 total
  • Sale

    Common Stock

    [F1]
    2026-01-09$532.50/sh−80$42,600→ 189,804 total
  • Sale

    Common Stock

    [F1][F21]
    2026-01-09$534.16/sh−332$177,342→ 189,472 total
  • Sale

    Common Stock

    [F1][F22]
    2026-01-09$535.29/sh−148$79,223→ 189,324 total
  • Sale

    Common Stock

    [F1][F23]
    2026-01-09$536.02/sh−473$253,538→ 188,851 total
  • Sale

    Common Stock

    [F1][F24]
    2026-01-09$536.88/sh−487$261,459→ 188,364 total
  • Sale

    Common Stock

    [F1][F25]
    2026-01-09$537.85/sh−80$43,028→ 188,284 total
  • Sale

    Common Stock

    [F1][F26]
    2026-01-09$539.23/sh−480$258,831→ 187,804 total
  • Sale

    Common Stock

    [F1][F27]
    2026-01-09$540.36/sh−600$324,215→ 187,204 total
  • Sale

    Common Stock

    [F1]
    2026-01-09$545.79/sh−40$21,832→ 187,164 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    [F29]
    2026-01-09−24,520→ 280 total
    Exercise: $15.80Exp: 2027-03-02→ Common Stock (24,520 underlying)
Holdings

  • Common Stock

    [F28]
    (indirect: By LLC)
    655,540
Footnotes (29)
  • [F1]These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 10, 2025.
  • [F10]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $520.48 to $521.45, inclusive.
  • [F11]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $521.49 to $522.40, inclusive.
  • [F12]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $522.49 to $523.46, inclusive.
  • [F13]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $523.51 to $524.48, inclusive.
  • [F14]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $524.51 to $525.49, inclusive.
  • [F15]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $525.55 to $526.50, inclusive.
  • [F16]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $526.56 to $527.51, inclusive.
  • [F17]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $527.56 to $528.53, inclusive.
  • [F18]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $528.56 to $529.52, inclusive.
  • [F19]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $529.56 to $530.12, inclusive.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $511.71 to $512.51, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and the footnotes below.
  • [F20]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $530.63 to $531.03, inclusive.
  • [F21]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $533.60 to $534.54, inclusive.
  • [F22]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $534.60 to $535.57, inclusive.
  • [F23]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $535.62 to $536.57, inclusive.
  • [F24]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $536.64 to $537.11, inclusive.
  • [F25]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $537.83 to $537.86, inclusive.
  • [F26]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $539.00 to $539.42, inclusive.
  • [F27]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $540.25 to $540.38, inclusive.
  • [F28]The Reporting Person and his spouse are each managing members of SQN, LLC. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, if any, and the inclusion of these shares in this report shall not be deemed an admission of the beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
  • [F29]The shares underlying this stock option are fully vested and exercisable.
  • [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $512.77 to $513.60, inclusive.
  • [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $514.28 to $515.22, inclusive.
  • [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $515.29 to $516.21, inclusive.
  • [F6]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $516.34 to $517.28, inclusive.
  • [F7]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $517.36 to $518.35, inclusive.
  • [F8]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $518.38 to $519.37, inclusive.
  • [F9]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $519.45 to $520.42, inclusive.
Signature
/s/ Mardi Dier, as Attorney-in-Fact|2026-01-13

Documents

1 file

Issuer

MADRIGAL PHARMACEUTICALS, INC.

CIK 0001157601

→
Entity typeother

Related Parties

1
  • filerCIK 0001236927

Filing Metadata

Form type
4
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:43 PM ET
Size
54.0 KB
View on SEC.gov